Cargando…
Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment
OBJECTIVE: To evaluate contrast-enhanced ultrasound (CEUS) for monitoring early intrahepatic recurrence of primary hepatocellular carcinoma (HCC) after curative treatment. METHODS: We prospectively analyzed 97 patients (124 nodules) with primary HCC who underwent hepatic resection or radiofrequency...
Autores principales: | Liu, Lian-Feng, Ding, Zhan-Ling, Zhong, Jian-Hong, Li, Hong-Xue, Liu, Jun-Jie, Li, Hang, Li, Le-Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247733/ https://www.ncbi.nlm.nih.gov/pubmed/30533441 http://dx.doi.org/10.1155/2018/8910562 |
Ejemplares similares
-
Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy
por: Wang, Hong-Liang, et al.
Publicado: (2019) -
Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy
por: Wang, Yan-Yan, et al.
Publicado: (2014) -
Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy
por: Mo, Han-Yue, et al.
Publicado: (2017) -
Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy
por: Tu, Hai-Bin, et al.
Publicado: (2021) -
Value of ultrasound combined with MRI in the diagnosis of primary and recurrent hepatocellular carcinoma
por: Ji, Xiaoli, et al.
Publicado: (2019)